- Report
- March 2025
- 50 Pages
Greece
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Finland
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Denmark
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Norway
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Austria
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Ireland
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Sweden
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Russia
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Poland
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Belgium
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Vietnam
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Taiwan
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Turkey
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Israel
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Brazil
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
India
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Japan
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
China
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Spain
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Italy
From €550EUR$600USD£467GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more